Stepan Stock Price, News & Analysis

Stepan Company (NYSE: SCL) reported record third-quarter results for 2022, with net income reaching $39.4 million ($1.71 per diluted share), up 7% year-over-year. Adjusted net income rose to $46.3 million ($2.01 per diluted share), marking a 27% increase. Despite a total sales volume decrease of 8%, the company achieved a 19% rise in net sales due to higher selling prices. Surfactants and Specialty Products sectors reported significant operating income growth, while Polymer segment income increased by 61% despite a 10% volume decline. The company also increased its quarterly dividend by 9%.

On October 18, 2022, Stepan Company (NYSE:SCL) announced a 9.0% increase in its quarterly cash dividend, raising it by $0.030 to $0.365 per share. This dividend, marking the 55th consecutive year of increases, will be payable on December 15, 2022, to stockholders of record on November 30, 2022. Stepan Company specializes in manufacturing chemicals used across numerous industries, including cleaning products and polyurethane polyols for thermal insulation.

Stepan Company (NYSE: SCL) has finalized its acquisition of PerformanX Specialty Chemicals, which includes vital intellectual property, commercial relationships, and inventory. This acquisition strengthens Stepan's position in alkoxylates, essential for various markets such as agriculture and oilfield solutions. The financial terms of the deal remain undisclosed. CEO Scott R. Behrens expressed enthusiasm over welcoming PerformanX's customers and highlighted the strategic significance this acquisition brings to Stepan's product offerings and market presence.

Stepan Company (NYSE: SCL) will release its third quarter 2022 earnings results on October 19, 2022, at 7:00 am ET. A conference call hosted by CEO Scott R. Behrens and CFO Luis E. Rojo will follow at 10:00 am ET. The earnings and supporting slides will be accessible on the company's website. Stepan is a major manufacturer of specialty chemicals, focusing on surfactants and polyurethane products, and operates globally from multiple production facilities. The company emphasizes its commitment to sustainability.

Stepan Company (NYSE: SCL) announced an agreement to acquire the surfactant business of PerformanX Specialty Chemicals, enhancing its product line and market diversification. This strategic acquisition is projected to add approximately $20 million to annual revenue and improve Stepan's EBITDA margin. The deal, pending closing conditions, is expected to finalize in Q3 2022. Additionally, Stepan is set to enhance its alkoxylation capacity in Pasadena, Texas, with a $245 million investment, slated to start operations in early 2024, addressing rising global demand.

Stepan Company (NYSE: SCL) reported a record net income of $52.1 million, or $2.26 per diluted share, for Q2 2022, a 20% increase from $43.3 million a year prior. Adjusted net income was $53.0 million, up 26%. However, total sales volume declined by 1%. Surfactant operating income rose 5% to $48.2 million, while Polymer operating income surged 47% to $33.9 million. The company faced challenges from raw material constraints, resulting in a $1.9 million negative impact due to currency translation. The outlook remains cautiously optimistic despite inflationary pressures.

On July 26, 2022, Stepan Company (NYSE:SCL) declared a quarterly cash dividend of $0.335 per share, payable on September 15, 2022. Stockholders on record by August 31, 2022 will receive this dividend. This increase marks the 54th consecutive year of dividend growth, showcasing the company's commitment to returning value to its shareholders. Stepan specializes in manufacturing specialty chemicals for various industries and operates globally across North America, South America, Europe, and Asia.

Stepan Company (NYSE: SCL) will announce its second quarter 2022 earnings on July 27, 2022, around 7:00 am ET. A conference call hosted by President and CEO Scott R. Behrens and CFO Luis E. Rojo will follow at 10:00 am ET to discuss financial results. The company specializes in manufacturing specialty and intermediate chemicals across various industries, particularly in surfactants and polyurethane polyols. The earnings report will provide insights into operational performance, reflecting Stepan's market position and strategic initiatives.

Stepan Company (NYSE: SCL) announced a new five-year credit agreement totaling $450 million, comprising a $350 million multi-currency revolving credit facility and a $100 million delayed draw term loan. These facilities, arranged by JPMorgan Chase Bank and BofA Securities, will mature on June 24, 2027, and are aimed at supporting working capital, acquisitions, and capital expenditures. This agreement replaces the previous credit facility set to expire in January 2023. CEO Scott R. Behrens highlighted the deal as a strategic step for growth and acquisitions.